ICAM3 and neoplasm: In cervical cancer, the induction of ICAM-3 has been shown to confer radioresistance to tumour cells and anticancer drug resistance via activation of the Akt/ERK-CREB-2 signalling pathway, which induces cancer cell proliferation and reduces apoptosis [172].